REPORTS

Let’s Pullulate and Expand Your Business

Global Gastrointestinal Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Oct 12, 2019  |  138 PAGES  |  REPORT CODE: CMM206846
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Gastrointestinal Therapeutics is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period. The research provides insights for the global Gastrointestinal Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Gastrointestinal Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Gastrointestinal Therapeutics Market Segmentations:

By Players:

  • Amgen

  • F. Hoffmann-La Roche

  • Kissei Pharmaceutical

  • Novartis

  • Kaken Pharmaceutical

  • RedHill Biopharma

  • Salix Pharmaceuticals

  • Takeda

  • Procter & Gamble

  • AstraZeneca

  • Merck

  • TSD Japan

  • Kang Stem Biotech

  • Ono Pharmaceutical

  • Hutchison Medi Pharma

  • Pfizer

  • Eli Lilly

  • Johnson & Johnson

  • Shire Pharmaceuticals

  • GlaxoSmithKline

  • Zeria Pharmaceutical

  • Tillotts Pharma

  • Allergan

  • AbbVie

By Types:

  • Type 1

  • Type 2

  • Type 3

By End-User:

  • IBD

  • Irritable Bowel Syndrome (IBS)

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastrointestinal Therapeutics Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Gastrointestinal Therapeutics Market Share by Types

    • 1.3.2 Global Gastrointestinal Therapeutics Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.3 Global Gastrointestinal Therapeutics Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.4 Global Gastrointestinal Therapeutics Market Size and Growth Rate of Type 3 from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Gastrointestinal Therapeutics Market Share by End-Users

    • 1.4.2 Global Gastrointestinal Therapeutics Market Size and Growth Rate of IBD from 2014 to 2026

    • 1.4.3 Global Gastrointestinal Therapeutics Market Size and Growth Rate of Irritable Bowel Syndrome (IBS) from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Gastrointestinal Therapeutics Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Gastrointestinal Therapeutics Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Gastrointestinal Therapeutics by Major Types

    • 3.4.1 Market Size and Growth Rate of Type 1

    • 3.4.2 Market Size and Growth Rate of Type 2

    • 3.4.3 Market Size and Growth Rate of Type 3

4 Segmentation of Gastrointestinal Therapeutics Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Gastrointestinal Therapeutics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Gastrointestinal Therapeutics for IBD

    • 4.4.2 Market Size and Growth Rate of Gastrointestinal Therapeutics for Irritable Bowel Syndrome (IBS)

5 Market Analysis by Major Regions

  • 5.1 Global Gastrointestinal Therapeutics Production Analysis by Major Regions

  • 5.2 Global Gastrointestinal Therapeutics Consumption Analysis by Major Regions

  • 5.3 Global Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis

6 Product Commodity of Gastrointestinal Therapeutics Market in Major Countries

  • 6.1 Top 5 Export Countries in Gastrointestinal Therapeutics market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Gastrointestinal Therapeutics market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Gastrointestinal Therapeutics Landscape Analysis

  • 7.1 North America Gastrointestinal Therapeutics Landscape Analysis by Major Types

  • 7.2 North America Gastrointestinal Therapeutics Landscape Analysis by Major End-Users

  • 7.3 North America Gastrointestinal Therapeutics Landscape Analysis by Major Countries

    • 7.3.1 United States Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 7.3.2 Canada Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 7.3.3 Mexico Gastrointestinal Therapeutics Market Volume and Growth Rate

8 Europe Gastrointestinal Therapeutics Landscape Analysis

  • 8.1 Europe Gastrointestinal Therapeutics Landscape Analysis by Major Types

  • 8.2 Europe Gastrointestinal Therapeutics Landscape Analysis by Major End-Users

  • 8.3 Europe Gastrointestinal Therapeutics Landscape Analysis by Major Countries

    • 8.3.1 Germany Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.2 UK Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.3 France Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.4 Italy Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.6 Spain Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.7 Belgium Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.8 Poland Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.9 Russia Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 8.3.10 Turkey Gastrointestinal Therapeutics Market Volume and Growth Rate

9 Asia Pacific Gastrointestinal Therapeutics Landscape Analysis

  • 9.1 Asia Pacific Gastrointestinal Therapeutics Landscape Analysis by Major Types

  • 9.2 Asia Pacific Gastrointestinal Therapeutics Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Gastrointestinal Therapeutics Landscape Analysis by Major Countries

    • 9.3.1 China Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 9.3.2 Japan Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 9.3.4 India Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 9.3.6 South Korea Gastrointestinal Therapeutics Market Volume and Growth Rate

10 Latin America, Middle East & Africa Gastrointestinal Therapeutics Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Gastrointestinal Therapeutics Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Gastrointestinal Therapeutics Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Gastrointestinal Therapeutics Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 10.3.2 Brazil Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 10.3.3 Nigeria Gastrointestinal Therapeutics Market Volume and Growth Rate

    • 10.3.4 South Africa Gastrointestinal Therapeutics Market Volume and Growth Rate 

    • 10.3.5 Argentina Gastrointestinal Therapeutics Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Amgen

    • 11.1.1 Amgen Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 F. Hoffmann-La Roche

    • 11.2.1 F. Hoffmann-La Roche Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Kissei Pharmaceutical

    • 11.3.1 Kissei Pharmaceutical Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Novartis

    • 11.4.1 Novartis Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Kaken Pharmaceutical

    • 11.5.1 Kaken Pharmaceutical Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 RedHill Biopharma

    • 11.6.1 RedHill Biopharma Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Salix Pharmaceuticals

    • 11.7.1 Salix Pharmaceuticals Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Takeda

    • 11.8.1 Takeda Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Procter & Gamble

    • 11.9.1 Procter & Gamble Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 AstraZeneca

    • 11.10.1 AstraZeneca Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Merck

    • 11.11.1 Merck Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 TSD Japan

    • 11.12.1 TSD Japan Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Kang Stem Biotech

    • 11.13.1 Kang Stem Biotech Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Ono Pharmaceutical

    • 11.14.1 Ono Pharmaceutical Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Hutchison Medi Pharma

    • 11.15.1 Hutchison Medi Pharma Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Pfizer

    • 11.16.1 Pfizer Company Profile and Development Status

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Eli Lilly

    • 11.17.1 Eli Lilly Company Profile and Development Status

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Johnson & Johnson

    • 11.18.1 Johnson & Johnson Company Profile and Development Status

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 Shire Pharmaceuticals

    • 11.19.1 Shire Pharmaceuticals Company Profile and Development Status

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

  • 11.20 GlaxoSmithKline

    • 11.20.1 GlaxoSmithKline Company Profile and Development Status

    • 11.20.2 Market Performance

    • 11.20.3 Product and Service Introduction

  • 11.21 Zeria Pharmaceutical

    • 11.21.1 Zeria Pharmaceutical Company Profile and Development Status

    • 11.21.2 Market Performance

    • 11.21.3 Product and Service Introduction

  • 11.22 Tillotts Pharma

    • 11.22.1 Tillotts Pharma Company Profile and Development Status

    • 11.22.2 Market Performance

    • 11.22.3 Product and Service Introduction

  • 11.23 Allergan

    • 11.23.1 Allergan Company Profile and Development Status

    • 11.23.2 Market Performance

    • 11.23.3 Product and Service Introduction

  • 11.24 AbbVie

    • 11.24.1 AbbVie Company Profile and Development Status

    • 11.24.2 Market Performance

    • 11.24.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 98 Figures and 130 Tables)

  • Figure Product Picture

  • Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate of Type 1 from 2014 to 2026

  • Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate of Type 2 from 2014 to 2026

  • Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate of Type 3 from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate of IBD from 2014 to 2026

  • Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate of Irritable Bowel Syndrome (IBS) from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Gastrointestinal Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Gastrointestinal Therapeutics Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Gastrointestinal Therapeutics

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Gastrointestinal Therapeutics by Different Types from 2014 to 2026

  • Table Consumption Share of Gastrointestinal Therapeutics by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Type 1

  • Figure Market Size and Growth Rate of Type 2

  • Figure Market Size and Growth Rate of Type 3

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Gastrointestinal Therapeutics by Different End-Users from 2014 to 2026

  • Table Consumption Share of Gastrointestinal Therapeutics by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of IBD

  • Figure Market Size and Growth Rate of Irritable Bowel Syndrome (IBS)

  • Table Global Gastrointestinal Therapeutics Production by Major Regions

  • Table Global Gastrointestinal Therapeutics Production Share by Major Regions

  • Figure Global Gastrointestinal Therapeutics Production Share by Major Regions in 2014

  • Figure Global Gastrointestinal Therapeutics Production Share by Major Regions in 2018

  • Figure Global Gastrointestinal Therapeutics Production Share by Major Regions in 2026

  • Table Global Gastrointestinal Therapeutics Consumption by Major Regions

  • Table Global Gastrointestinal Therapeutics Consumption Share by Major Regions

  • Figure Global Gastrointestinal Therapeutics Consumption Share by Major Regions in 2014

  • Figure Global Gastrointestinal Therapeutics Consumption Share by Major Regions in 2018

  • Figure Global Gastrointestinal Therapeutics Consumption Share by Major Regions in 2026

  • Table North America Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis

  • Table Europe Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Gastrointestinal Therapeutics market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Gastrointestinal Therapeutics Consumption by Types from 2014 to 2026

  • Table North America Gastrointestinal Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure North America Gastrointestinal Therapeutics Consumption Share by Types in 2014

  • Figure North America Gastrointestinal Therapeutics Consumption Share by Types in 2018

  • Figure North America Gastrointestinal Therapeutics Consumption Share by Types in 2026

  • Table North America Gastrointestinal Therapeutics Consumption by End-Users from 2014 to 2026

  • Table North America Gastrointestinal Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure North America Gastrointestinal Therapeutics Consumption Share by End-Users in 2014

  • Figure North America Gastrointestinal Therapeutics Consumption Share by End-Users in 2018

  • Figure North America Gastrointestinal Therapeutics Consumption Share by End-Users in 2026

  • Table North America Gastrointestinal Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table North America Gastrointestinal Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Gastrointestinal Therapeutics Consumption Share by Major Countries in 2014

  • Figure North America Gastrointestinal Therapeutics Consumption Share by Major Countries in 2018

  • Figure North America Gastrointestinal Therapeutics Consumption Share by Major Countries in 2026

  • Figure United States Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics Consumption by Types from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by Types in 2014

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by Types in 2018

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by Types in 2026

  • Table Europe Gastrointestinal Therapeutics Consumption by End-Users from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by End-Users in 2014

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by End-Users in 2018

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by End-Users in 2026

  • Table Europe Gastrointestinal Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table Europe Gastrointestinal Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by Major Countries in 2014

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by Major Countries in 2018

  • Figure Europe Gastrointestinal Therapeutics Consumption Share by Major Countries in 2026

  • Figure Germany Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure France Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics Consumption by Types from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by Types in 2014

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by Types in 2018

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by Types in 2026

  • Table Asia Pacific Gastrointestinal Therapeutics Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by End-Users in 2014

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by End-Users in 2018

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by End-Users in 2026

  • Table Asia Pacific Gastrointestinal Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Gastrointestinal Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Gastrointestinal Therapeutics Consumption Share by Major Countries in 2026

  • Figure China Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandGastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure India Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Gastrointestinal Therapeutics Consumption Share by Major Countries in 2026

  • Figure GCC Countries Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Gastrointestinal Therapeutics Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Amgen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

  • Figure Sales and Growth Rate Analysis of Amgen

  • Figure Revenue and Market Share Analysis of Amgen

  • Table Product and Service Introduction of Amgen

  • Table Company Profile and Development Status of F. Hoffmann-La Roche

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche

  • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche

  • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche

  • Table Product and Service Introduction of F. Hoffmann-La Roche

  • Table Company Profile and Development Status of Kissei Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kissei Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Kissei Pharmaceutical

  • Figure Revenue and Market Share Analysis of Kissei Pharmaceutical

  • Table Product and Service Introduction of Kissei Pharmaceutical

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of Kaken Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kaken Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Kaken Pharmaceutical

  • Figure Revenue and Market Share Analysis of Kaken Pharmaceutical

  • Table Product and Service Introduction of Kaken Pharmaceutical

  • Table Company Profile and Development Status of RedHill Biopharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RedHill Biopharma

  • Figure Sales and Growth Rate Analysis of RedHill Biopharma

  • Figure Revenue and Market Share Analysis of RedHill Biopharma

  • Table Product and Service Introduction of RedHill Biopharma

  • Table Company Profile and Development Status of Salix Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals

  • Table Product and Service Introduction of Salix Pharmaceuticals

  • Table Company Profile and Development Status of Takeda

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

  • Figure Sales and Growth Rate Analysis of Takeda

  • Figure Revenue and Market Share Analysis of Takeda

  • Table Product and Service Introduction of Takeda

  • Table Company Profile and Development Status of Procter & Gamble

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Procter & Gamble

  • Figure Sales and Growth Rate Analysis of Procter & Gamble

  • Figure Revenue and Market Share Analysis of Procter & Gamble

  • Table Product and Service Introduction of Procter & Gamble

  • Table Company Profile and Development Status of AstraZeneca

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

  • Figure Sales and Growth Rate Analysis of AstraZeneca

  • Figure Revenue and Market Share Analysis of AstraZeneca

  • Table Product and Service Introduction of AstraZeneca

  • Table Company Profile and Development Status of Merck

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

  • Figure Sales and Growth Rate Analysis of Merck

  • Figure Revenue and Market Share Analysis of Merck

  • Table Product and Service Introduction of Merck

  • Table Company Profile and Development Status of TSD Japan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TSD Japan

  • Figure Sales and Growth Rate Analysis of TSD Japan

  • Figure Revenue and Market Share Analysis of TSD Japan

  • Table Product and Service Introduction of TSD Japan

  • Table Company Profile and Development Status of Kang Stem Biotech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kang Stem Biotech

  • Figure Sales and Growth Rate Analysis of Kang Stem Biotech

  • Figure Revenue and Market Share Analysis of Kang Stem Biotech

  • Table Product and Service Introduction of Kang Stem Biotech

  • Table Company Profile and Development Status of Ono Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ono Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Ono Pharmaceutical

  • Figure Revenue and Market Share Analysis of Ono Pharmaceutical

  • Table Product and Service Introduction of Ono Pharmaceutical

  • Table Company Profile and Development Status of Hutchison Medi Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hutchison Medi Pharma

  • Figure Sales and Growth Rate Analysis of Hutchison Medi Pharma

  • Figure Revenue and Market Share Analysis of Hutchison Medi Pharma

  • Table Product and Service Introduction of Hutchison Medi Pharma

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Eli Lilly

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

  • Figure Sales and Growth Rate Analysis of Eli Lilly

  • Figure Revenue and Market Share Analysis of Eli Lilly

  • Table Product and Service Introduction of Eli Lilly

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of Shire Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Shire Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Shire Pharmaceuticals

  • Table Product and Service Introduction of Shire Pharmaceuticals

  • Table Company Profile and Development Status of GlaxoSmithKline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline

  • Table Product and Service Introduction of GlaxoSmithKline

  • Table Company Profile and Development Status of Zeria Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zeria Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Zeria Pharmaceutical

  • Figure Revenue and Market Share Analysis of Zeria Pharmaceutical

  • Table Product and Service Introduction of Zeria Pharmaceutical

  • Table Company Profile and Development Status of Tillotts Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tillotts Pharma

  • Figure Sales and Growth Rate Analysis of Tillotts Pharma

  • Figure Revenue and Market Share Analysis of Tillotts Pharma

  • Table Product and Service Introduction of Tillotts Pharma

  • Table Company Profile and Development Status of Allergan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

  • Figure Sales and Growth Rate Analysis of Allergan

  • Figure Revenue and Market Share Analysis of Allergan

  • Table Product and Service Introduction of Allergan

  • Table Company Profile and Development Status of AbbVie

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

  • Figure Sales and Growth Rate Analysis of AbbVie

  • Figure Revenue and Market Share Analysis of AbbVie

  • Table Product and Service Introduction of AbbVie


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top